Diffuse right ventricular fibrosis in heart failure with preserved ejection fraction and pulmonary hypertension

被引:52
|
作者
Patel, Ravi B. [1 ]
Li, Emily [1 ]
Benefield, Brandon C. [2 ]
Swat, Stanley A. [1 ]
Polsinelli, Vincenzo B. [1 ]
Carr, James C. [3 ]
Shah, Sanjiv J. [1 ]
Markl, Michael [3 ,4 ]
Collins, Jeremy D. [5 ]
Freed, Benjamin H. [1 ]
机构
[1] Northwestern Univ, Div Cardiol, Chicago, IL 60611 USA
[2] Northwestern Univ, Feinberg Cardiovasc & Renal Res Inst, Chicago, IL 60611 USA
[3] Northwestern Univ, Dept Radiol, Chicago, IL 60611 USA
[4] Northwestern Univ, Dept Biomed Engn, Chicago, IL 60611 USA
[5] Mayo Clin, Dept Radiol, Rochester, MN USA
来源
ESC HEART FAILURE | 2020年 / 7卷 / 01期
关键词
Heart failure with preserved ejection fraction; Right ventricle; Fibrosis; Pulmonary hypertension; Cardiac magnetic resonance; MAGNETIC-RESONANCE; DYSFUNCTION;
D O I
10.1002/ehf2.12565
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims While right ventricular (RV) dysfunction is associated with worse prognosis in co-morbid pulmonary hypertension and heart failure with preserved ejection fraction (PH-HFpEF), the mechanisms driving RV dysfunction are unclear. We evaluated the extent and clinical correlates of diffuse RV myocardial fibrosis in PH-HFpEF, as measured by cardiovascular magnetic resonance-derived extracellular volume (ECV). Methods and results We prospectively enrolled participants with PH-HFpEF (n = 14), pulmonary arterial hypertension (PAH; n = 13), and controls (n = 8). All participants underwent high-resolution cardiovascular magnetic resonance, and case subjects (PH-HFpEF and PAH) additionally underwent right heart catheterization. T1 mapping was performed using high-resolution modified look-locker inversion recovery with a 1 x 1 mm(2) in-plane resolution. RV free wall T1 values were quantified, and ECV was calculated. Participants with PH-HFpEF were older and carried higher rates of hypertension and obstructive sleep apnoea than those with PAH. While RV ECV was similar between PH-HFpEF and PAH (33.1 +/- 8.0 vs. 34.0 +/- 4.5%; P = 0.57), total pulmonary resistance was lower in PH-HFpEF compared with PAH [PH-HFpEF: 5.68 WU (4.70, 7.66 WU) vs. PAH: 8.59 WU (8.14, 12.57 WU); P = 0.01]. RV ECV in PH-HFpEF was associated with worse indices of RV structure (RV end-diastolic volume: r = 0.67, P = 0.01) and RV function (RV free wall strain: r = 0.59, P = 0.03) but was not associated with RV afterload (total pulmonary resistance: r = 0.08, P = 0.79). Conversely, there was a strong correlation between RV ECV and RV afterload in PAH (r = 0.57, P = 0.04). Conclusions Diffuse RV fibrosis, as measured by ECV, is present in PH-HFpEF and is associated with adverse RV structural and functional remodelling but not degree of pulmonary vasculopathy. In PH-HFpEF, diffuse RV fibrosis may occur out of proportion to the degree of RV afterload.
引用
收藏
页码:254 / 264
页数:11
相关论文
共 50 条
  • [31] Management of Pulmonary Hypertension due to Heart Failure with Preserved Ejection Fraction
    Kanwar, Manreet
    Tedford, Ryan J.
    Agarwal, Richa
    Clarke, Megan M.
    Walter, Claire
    Sokos, George
    Murali, Srinivas
    Benza, Raymond L.
    CURRENT HYPERTENSION REPORTS, 2014, 16 (12) : 1 - 9
  • [32] OUTCOMES OF PULMONARY HYPERTENSION ASSOCIATED WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION
    Thenappan, Thenappan
    Shah, Sanjiv
    Rich, Stuart
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (13) : E1602 - E1602
  • [33] Management of Pulmonary Hypertension due to Heart Failure with Preserved Ejection Fraction
    Manreet Kanwar
    Ryan J. Tedford
    Richa Agarwal
    Megan M. Clarke
    Claire Walter
    George Sokos
    Srinivas Murali
    Raymond L. Benza
    Current Hypertension Reports, 2014, 16
  • [34] Pulmonary Hypertension Due to Heart Failure with Preserved Ejection Fraction in Rats
    Hubesch, G.
    Dewachter, C.
    Vegh, G.
    Jespers, P.
    Vachiery, J. E.
    Mc Entee, K.
    Dewachter, L.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [35] The neurohormonal basis of pulmonary hypertension in heart failure with preserved ejection fraction
    Obokata, Masaru
    Kane, Garvan C.
    Reddy, Yogesh N. V.
    Melenovsky, Vojtech
    Olson, Thomas P.
    Jarolim, Petr
    Borlaug, Barry A.
    EUROPEAN HEART JOURNAL, 2019, 40 (45) : 3707 - 3717
  • [36] Pulmonary hypertension with a precapillary component in heart failure with preserved ejection fraction
    Sera, Fusako
    Ohtani, Tomohito
    Tamaki, Shunsuke
    Yano, Masamichi
    Hayashi, Takaharu
    Nakagawa, Akito
    Nakagawa, Yusuke
    Nakatani, Daisaku
    Yamada, Takahisa
    Yasumura, Yoshio
    Hikoso, Shungo
    Yamauchi-Takihara, Keiko
    Sakata, Yasushi
    HEART, 2023, 109 (08) : 626 - 633
  • [37] Management of Pulmonary Hypertension in the Context of Heart Failure with Preserved Ejection Fraction
    Kozaily, Elie
    Akdogan, Ecem Raziye
    Dorsey, Natalie Stringer
    Tedford, Ryan J.
    CURRENT HYPERTENSION REPORTS, 2024, 26 (07) : 291 - 306
  • [38] Prognostic importance of pulmonary hypertension in heart failure with preserved ejection fraction
    Carrasco-Sanchez, F. J.
    Ortiz-Lopez, E.
    Galisteo-Almeda, L.
    Camacho-Vazquez, C.
    Ruiz-Frutos, C.
    Pujol-De La Llave, E.
    REVISTA CLINICA ESPANOLA, 2010, 210 (10): : 489 - 496
  • [39] Heart failure with preserved ejection fraction in hypertension
    Teo, Loon Yee Louis
    Chan, Laura Lihua
    Lam, Carolyn Su Ping
    CURRENT OPINION IN CARDIOLOGY, 2016, 31 (04) : 410 - 416
  • [40] Hypertension and Heart Failure with Preserved Ejection Fraction
    Lee, Chan Joo
    Park, Sungha
    HEART FAILURE CLINICS, 2021, 17 (03) : 337 - 343